BioCentury
ARTICLE | Company News

Schering spins out metaGen

March 20, 2001 8:00 AM UTC

Apax Partners invested EUR42 million for a 50 percent stake in cancer genomics company metaGen (Berlin, Germany), which was spun out by Schering (SHR; FSE:SCH). SHR retains a 43.5 percent stake and me...